← Back
Data updated: Jul 17, 2026
INTL ISOTOPES
Generics Pharmaceuticals
INTL ISOTOPES is a generic drug manufacturer with 1 FDA-approved products.
2020
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
INTL ISOTOPES's Key Drugs
INTL ISOTOPES's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
INTL ISOTOPES's Recent FDA Approvals
New NDA/BLA approvals for INTL ISOTOPES over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
INTL ISOTOPES's Therapeutic Areas
Disease areas where INTL ISOTOPES has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
INTL ISOTOPES Pipeline Snapshot
Active clinical trials for INTL ISOTOPES across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2020-02-05
- Latest
- 2020-02-05
- Applications
- 1